BlackRock Inc. - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,468,000
-70.4%
1,524,309
-63.4%
0.00%
Q1 2022$4,963,000
-64.0%
4,170,141
-1.5%
0.00%
Q4 2021$13,798,000
-29.1%
4,232,268
-2.8%
0.00%
-100.0%
Q3 2021$19,461,000
-20.0%
4,353,672
-2.5%
0.00%0.0%
Q2 2021$24,325,000
-22.0%
4,463,356
+7.1%
0.00%0.0%
Q1 2021$31,175,000
-13.6%
4,167,964
+25.3%
0.00%0.0%
Q4 2020$36,082,000
+23.3%
3,325,560
+0.5%
0.00%0.0%
Q3 2020$29,260,000
-17.4%
3,309,868
-0.4%
0.00%0.0%
Q2 2020$35,424,000
+112.1%
3,322,898
+18.0%
0.00%0.0%
Q1 2020$16,698,000
-15.6%
2,815,950
-1.7%
0.00%0.0%
Q4 2019$19,787,000
-30.5%
2,863,412
+4.3%
0.00%0.0%
Q3 2019$28,490,000
+15.4%
2,744,760
+2.9%
0.00%0.0%
Q2 2019$24,698,000
+34.4%
2,667,156
+32.7%
0.00%0.0%
Q1 2019$18,375,000
+66.1%
2,010,421
+1.2%
0.00%0.0%
Q4 2018$11,063,000
-42.4%
1,986,130
+23.1%
0.00%0.0%
Q3 2018$19,219,000
+18.9%
1,613,668
+1.9%
0.00%0.0%
Q2 2018$16,169,000
+34.0%
1,583,631
+70.4%
0.00%0.0%
Q1 2018$12,066,000
+115.7%
929,537
+61.7%
0.00%
Q4 2017$5,593,000
-33.3%
574,946
+0.9%
0.00%
Q3 2017$8,387,000
-4.3%
569,796
+4.6%
0.00%
Q2 2017$8,762,000
+206.7%
544,530
+203.6%
0.00%
Q1 2017$2,857,000
+95133.3%
179,368
+72813.8%
0.00%
Q4 2016$3,0002460.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders